Predictors of non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph node : pilot study

Background: Sentinel Lymph Node Biopsy (SLNB) procedure was found to be an accurate method of staging the axilla in patients with early stage breast cancer. The standard of care for breast cancer patients with positive SLN metastasis includes complete Axillary Lymph Node Dissection (ALND). However,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of Egyptian National Cancer Institute 2012, Vol.24 (1), p.23-30
Hauptverfasser: al-Khalili, Khalid, al-Dweny, Hani, Abd al-Samad, Majidah, Abbas, Ahmad, Hamad, Ahmad, Munib, Sharif, Isam, Tariq, Kukawski, Pawel, Bobin, Jean-Yves, Oteifa, Midhat, Amanguono, Henney, Abu al-Huda, Fawwaz, Usmani, Sharjeel, al-Basmy, Amani, al-Salih, Nuha
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 30
container_issue 1
container_start_page 23
container_title Journal of Egyptian National Cancer Institute
container_volume 24
creator al-Khalili, Khalid
al-Dweny, Hani
Abd al-Samad, Majidah
Abbas, Ahmad
Hamad, Ahmad
Munib, Sharif
Isam, Tariq
Kukawski, Pawel
Bobin, Jean-Yves
Oteifa, Midhat
Amanguono, Henney
Abu al-Huda, Fawwaz
Usmani, Sharjeel
al-Basmy, Amani
al-Salih, Nuha
description Background: Sentinel Lymph Node Biopsy (SLNB) procedure was found to be an accurate method of staging the axilla in patients with early stage breast cancer. The standard of care for breast cancer patients with positive SLN metastasis includes complete Axillary Lymph Node Dissection (ALND). However, in 40–70 % of patients, the SLN is the only involved axillary node. Factors predicting non SLN metastasis should be identified in order to define subgroups of patients with positive SLN in whom the axilla may be staged by SLNB alone. Objectives : to identify the factors predicting metastatic involvement of the non-SLNs in breast cancer patients having SLN metastasis. Patients and Methods : data were collected and analyzed from 80 patients with early stage invasive breast cancer (T1, T2, N0, M0) who underwent SLNB at the Surgical Oncology Department, Kuwait Cancer Control Center (KCCC) between November 2004 and February 2009. SLNB was performed using a combined technique (radioactive colloid, and blue dye) in the majority of cases. In some cases, only one technique was used. Complete ALND was performed in the case of failure of SLN identification and in patients with positive SLN. Multiple variables (patient, tumor, and SLN characteristics) were tested as possible predictors of no sentinel lymph node metastasis. Results : the mean age of patients at diagnosis was 46.6 years. The median tumor size was 2 cm. The SLN identification rate was 96.2% (77 out of 80 patients). The SLN was positive in 24 patients (31 %), and half of these showed evidence of capsular invasion. The median number of SLNs removed was two. The median number of positive SLNs was one. The incidence of non-SLN metastasis associated with positive SLN was 50% (12 out of 24 patients). Lymph vascular invasion was found to be the only factor associated with non-SLN metastases. In addition, two trends were observed, though they did not reach the statistical significance: the first is that the majority of patients having capsular invasion of the SLN (8 out of 12 patients, 67 %) had positive non-SLN metastasis, and the second is that the patients having more than one SLN metastasis were more likely to have non-SLN metastasis (4 out of 5, 80 %). Conclusion : in the current pilot study, only the lymph vascular invasion in the area of the primary tumor was found to be significantly related to the no sentinel lymph node metastasis. There was a tendency toward higher incidence of no sentinel lymph node metasta
format Article
fullrecord <record><control><sourceid>emarefa</sourceid><recordid>TN_cdi_emarefa_primary_312849</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>312849</sourcerecordid><originalsourceid>FETCH-emarefa_primary_3128493</originalsourceid><addsrcrecordid>eNqFTMsKwjAQDKLg8xOE_YFCajVtvYri0YN3ie0WV9okZKNSv94cPArCwLyYGYhJqoo8KctSDaNOU5nITK3GYsp8l1IpmW8m4n3yWFMVrGewDRhrEkYTyGALbd-5W4xqhA6D5ghiIANXj9FBpU2FHpwOFCcMLwo3cJYp0BPh180WHLU2AIdH3c_FqNEt4-LLM7E87M-7Y4Kd9tjoi_MUVX_J0lWxLrN__QcuOEzi</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Predictors of non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph node : pilot study</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>al-Khalili, Khalid ; al-Dweny, Hani ; Abd al-Samad, Majidah ; Abbas, Ahmad ; Hamad, Ahmad ; Munib, Sharif ; Isam, Tariq ; Kukawski, Pawel ; Bobin, Jean-Yves ; Oteifa, Midhat ; Amanguono, Henney ; Abu al-Huda, Fawwaz ; Usmani, Sharjeel ; al-Basmy, Amani ; al-Salih, Nuha</creator><creatorcontrib>al-Khalili, Khalid ; al-Dweny, Hani ; Abd al-Samad, Majidah ; Abbas, Ahmad ; Hamad, Ahmad ; Munib, Sharif ; Isam, Tariq ; Kukawski, Pawel ; Bobin, Jean-Yves ; Oteifa, Midhat ; Amanguono, Henney ; Abu al-Huda, Fawwaz ; Usmani, Sharjeel ; al-Basmy, Amani ; al-Salih, Nuha</creatorcontrib><description>Background: Sentinel Lymph Node Biopsy (SLNB) procedure was found to be an accurate method of staging the axilla in patients with early stage breast cancer. The standard of care for breast cancer patients with positive SLN metastasis includes complete Axillary Lymph Node Dissection (ALND). However, in 40–70 % of patients, the SLN is the only involved axillary node. Factors predicting non SLN metastasis should be identified in order to define subgroups of patients with positive SLN in whom the axilla may be staged by SLNB alone. Objectives : to identify the factors predicting metastatic involvement of the non-SLNs in breast cancer patients having SLN metastasis. Patients and Methods : data were collected and analyzed from 80 patients with early stage invasive breast cancer (T1, T2, N0, M0) who underwent SLNB at the Surgical Oncology Department, Kuwait Cancer Control Center (KCCC) between November 2004 and February 2009. SLNB was performed using a combined technique (radioactive colloid, and blue dye) in the majority of cases. In some cases, only one technique was used. Complete ALND was performed in the case of failure of SLN identification and in patients with positive SLN. Multiple variables (patient, tumor, and SLN characteristics) were tested as possible predictors of no sentinel lymph node metastasis. Results : the mean age of patients at diagnosis was 46.6 years. The median tumor size was 2 cm. The SLN identification rate was 96.2% (77 out of 80 patients). The SLN was positive in 24 patients (31 %), and half of these showed evidence of capsular invasion. The median number of SLNs removed was two. The median number of positive SLNs was one. The incidence of non-SLN metastasis associated with positive SLN was 50% (12 out of 24 patients). Lymph vascular invasion was found to be the only factor associated with non-SLN metastases. In addition, two trends were observed, though they did not reach the statistical significance: the first is that the majority of patients having capsular invasion of the SLN (8 out of 12 patients, 67 %) had positive non-SLN metastasis, and the second is that the patients having more than one SLN metastasis were more likely to have non-SLN metastasis (4 out of 5, 80 %). Conclusion : in the current pilot study, only the lymph vascular invasion in the area of the primary tumor was found to be significantly related to the no sentinel lymph node metastasis. There was a tendency toward higher incidence of no sentinel lymph node metastasis associated with the number of positive SLN and capsular invasion of SLN, though this did not reach the statistical significance. This could be attributed to the small number of patients recruited. Further evaluation of the predictors of no sentinel lymph node metastasis on a larger number of patients is required. The validation of these predictors in prospective studies may enable approximately half of early stage breast cancer patients with positive SLN to be staged with SLNB alone while avoiding the morbidity of unnecessary ALND.</description><identifier>ISSN: 1110-0362</identifier><identifier>EISSN: 1687-9996</identifier><language>eng</language><publisher>Cairo, Egypt: Cairo University, National Cancer Institute</publisher><subject>Breast ; Cancer ; Lymph nodes ; الثدي ; السرطان</subject><ispartof>Journal of Egyptian National Cancer Institute, 2012, Vol.24 (1), p.23-30</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids></links><search><creatorcontrib>al-Khalili, Khalid</creatorcontrib><creatorcontrib>al-Dweny, Hani</creatorcontrib><creatorcontrib>Abd al-Samad, Majidah</creatorcontrib><creatorcontrib>Abbas, Ahmad</creatorcontrib><creatorcontrib>Hamad, Ahmad</creatorcontrib><creatorcontrib>Munib, Sharif</creatorcontrib><creatorcontrib>Isam, Tariq</creatorcontrib><creatorcontrib>Kukawski, Pawel</creatorcontrib><creatorcontrib>Bobin, Jean-Yves</creatorcontrib><creatorcontrib>Oteifa, Midhat</creatorcontrib><creatorcontrib>Amanguono, Henney</creatorcontrib><creatorcontrib>Abu al-Huda, Fawwaz</creatorcontrib><creatorcontrib>Usmani, Sharjeel</creatorcontrib><creatorcontrib>al-Basmy, Amani</creatorcontrib><creatorcontrib>al-Salih, Nuha</creatorcontrib><title>Predictors of non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph node : pilot study</title><title>Journal of Egyptian National Cancer Institute</title><description>Background: Sentinel Lymph Node Biopsy (SLNB) procedure was found to be an accurate method of staging the axilla in patients with early stage breast cancer. The standard of care for breast cancer patients with positive SLN metastasis includes complete Axillary Lymph Node Dissection (ALND). However, in 40–70 % of patients, the SLN is the only involved axillary node. Factors predicting non SLN metastasis should be identified in order to define subgroups of patients with positive SLN in whom the axilla may be staged by SLNB alone. Objectives : to identify the factors predicting metastatic involvement of the non-SLNs in breast cancer patients having SLN metastasis. Patients and Methods : data were collected and analyzed from 80 patients with early stage invasive breast cancer (T1, T2, N0, M0) who underwent SLNB at the Surgical Oncology Department, Kuwait Cancer Control Center (KCCC) between November 2004 and February 2009. SLNB was performed using a combined technique (radioactive colloid, and blue dye) in the majority of cases. In some cases, only one technique was used. Complete ALND was performed in the case of failure of SLN identification and in patients with positive SLN. Multiple variables (patient, tumor, and SLN characteristics) were tested as possible predictors of no sentinel lymph node metastasis. Results : the mean age of patients at diagnosis was 46.6 years. The median tumor size was 2 cm. The SLN identification rate was 96.2% (77 out of 80 patients). The SLN was positive in 24 patients (31 %), and half of these showed evidence of capsular invasion. The median number of SLNs removed was two. The median number of positive SLNs was one. The incidence of non-SLN metastasis associated with positive SLN was 50% (12 out of 24 patients). Lymph vascular invasion was found to be the only factor associated with non-SLN metastases. In addition, two trends were observed, though they did not reach the statistical significance: the first is that the majority of patients having capsular invasion of the SLN (8 out of 12 patients, 67 %) had positive non-SLN metastasis, and the second is that the patients having more than one SLN metastasis were more likely to have non-SLN metastasis (4 out of 5, 80 %). Conclusion : in the current pilot study, only the lymph vascular invasion in the area of the primary tumor was found to be significantly related to the no sentinel lymph node metastasis. There was a tendency toward higher incidence of no sentinel lymph node metastasis associated with the number of positive SLN and capsular invasion of SLN, though this did not reach the statistical significance. This could be attributed to the small number of patients recruited. Further evaluation of the predictors of no sentinel lymph node metastasis on a larger number of patients is required. The validation of these predictors in prospective studies may enable approximately half of early stage breast cancer patients with positive SLN to be staged with SLNB alone while avoiding the morbidity of unnecessary ALND.</description><subject>Breast</subject><subject>Cancer</subject><subject>Lymph nodes</subject><subject>الثدي</subject><subject>السرطان</subject><issn>1110-0362</issn><issn>1687-9996</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNqFTMsKwjAQDKLg8xOE_YFCajVtvYri0YN3ie0WV9okZKNSv94cPArCwLyYGYhJqoo8KctSDaNOU5nITK3GYsp8l1IpmW8m4n3yWFMVrGewDRhrEkYTyGALbd-5W4xqhA6D5ghiIANXj9FBpU2FHpwOFCcMLwo3cJYp0BPh180WHLU2AIdH3c_FqNEt4-LLM7E87M-7Y4Kd9tjoi_MUVX_J0lWxLrN__QcuOEzi</recordid><startdate>2012</startdate><enddate>2012</enddate><creator>al-Khalili, Khalid</creator><creator>al-Dweny, Hani</creator><creator>Abd al-Samad, Majidah</creator><creator>Abbas, Ahmad</creator><creator>Hamad, Ahmad</creator><creator>Munib, Sharif</creator><creator>Isam, Tariq</creator><creator>Kukawski, Pawel</creator><creator>Bobin, Jean-Yves</creator><creator>Oteifa, Midhat</creator><creator>Amanguono, Henney</creator><creator>Abu al-Huda, Fawwaz</creator><creator>Usmani, Sharjeel</creator><creator>al-Basmy, Amani</creator><creator>al-Salih, Nuha</creator><general>Cairo University, National Cancer Institute</general><scope>ADJCN</scope><scope>AFFIF</scope><scope>AHFXO</scope></search><sort><creationdate>2012</creationdate><title>Predictors of non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph node : pilot study</title><author>al-Khalili, Khalid ; al-Dweny, Hani ; Abd al-Samad, Majidah ; Abbas, Ahmad ; Hamad, Ahmad ; Munib, Sharif ; Isam, Tariq ; Kukawski, Pawel ; Bobin, Jean-Yves ; Oteifa, Midhat ; Amanguono, Henney ; Abu al-Huda, Fawwaz ; Usmani, Sharjeel ; al-Basmy, Amani ; al-Salih, Nuha</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-emarefa_primary_3128493</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Breast</topic><topic>Cancer</topic><topic>Lymph nodes</topic><topic>الثدي</topic><topic>السرطان</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>al-Khalili, Khalid</creatorcontrib><creatorcontrib>al-Dweny, Hani</creatorcontrib><creatorcontrib>Abd al-Samad, Majidah</creatorcontrib><creatorcontrib>Abbas, Ahmad</creatorcontrib><creatorcontrib>Hamad, Ahmad</creatorcontrib><creatorcontrib>Munib, Sharif</creatorcontrib><creatorcontrib>Isam, Tariq</creatorcontrib><creatorcontrib>Kukawski, Pawel</creatorcontrib><creatorcontrib>Bobin, Jean-Yves</creatorcontrib><creatorcontrib>Oteifa, Midhat</creatorcontrib><creatorcontrib>Amanguono, Henney</creatorcontrib><creatorcontrib>Abu al-Huda, Fawwaz</creatorcontrib><creatorcontrib>Usmani, Sharjeel</creatorcontrib><creatorcontrib>al-Basmy, Amani</creatorcontrib><creatorcontrib>al-Salih, Nuha</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>قاعدة دراسات المرأة - e-Marefa Women Studies</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><jtitle>Journal of Egyptian National Cancer Institute</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>al-Khalili, Khalid</au><au>al-Dweny, Hani</au><au>Abd al-Samad, Majidah</au><au>Abbas, Ahmad</au><au>Hamad, Ahmad</au><au>Munib, Sharif</au><au>Isam, Tariq</au><au>Kukawski, Pawel</au><au>Bobin, Jean-Yves</au><au>Oteifa, Midhat</au><au>Amanguono, Henney</au><au>Abu al-Huda, Fawwaz</au><au>Usmani, Sharjeel</au><au>al-Basmy, Amani</au><au>al-Salih, Nuha</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Predictors of non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph node : pilot study</atitle><jtitle>Journal of Egyptian National Cancer Institute</jtitle><date>2012</date><risdate>2012</risdate><volume>24</volume><issue>1</issue><spage>23</spage><epage>30</epage><pages>23-30</pages><issn>1110-0362</issn><eissn>1687-9996</eissn><abstract>Background: Sentinel Lymph Node Biopsy (SLNB) procedure was found to be an accurate method of staging the axilla in patients with early stage breast cancer. The standard of care for breast cancer patients with positive SLN metastasis includes complete Axillary Lymph Node Dissection (ALND). However, in 40–70 % of patients, the SLN is the only involved axillary node. Factors predicting non SLN metastasis should be identified in order to define subgroups of patients with positive SLN in whom the axilla may be staged by SLNB alone. Objectives : to identify the factors predicting metastatic involvement of the non-SLNs in breast cancer patients having SLN metastasis. Patients and Methods : data were collected and analyzed from 80 patients with early stage invasive breast cancer (T1, T2, N0, M0) who underwent SLNB at the Surgical Oncology Department, Kuwait Cancer Control Center (KCCC) between November 2004 and February 2009. SLNB was performed using a combined technique (radioactive colloid, and blue dye) in the majority of cases. In some cases, only one technique was used. Complete ALND was performed in the case of failure of SLN identification and in patients with positive SLN. Multiple variables (patient, tumor, and SLN characteristics) were tested as possible predictors of no sentinel lymph node metastasis. Results : the mean age of patients at diagnosis was 46.6 years. The median tumor size was 2 cm. The SLN identification rate was 96.2% (77 out of 80 patients). The SLN was positive in 24 patients (31 %), and half of these showed evidence of capsular invasion. The median number of SLNs removed was two. The median number of positive SLNs was one. The incidence of non-SLN metastasis associated with positive SLN was 50% (12 out of 24 patients). Lymph vascular invasion was found to be the only factor associated with non-SLN metastases. In addition, two trends were observed, though they did not reach the statistical significance: the first is that the majority of patients having capsular invasion of the SLN (8 out of 12 patients, 67 %) had positive non-SLN metastasis, and the second is that the patients having more than one SLN metastasis were more likely to have non-SLN metastasis (4 out of 5, 80 %). Conclusion : in the current pilot study, only the lymph vascular invasion in the area of the primary tumor was found to be significantly related to the no sentinel lymph node metastasis. There was a tendency toward higher incidence of no sentinel lymph node metastasis associated with the number of positive SLN and capsular invasion of SLN, though this did not reach the statistical significance. This could be attributed to the small number of patients recruited. Further evaluation of the predictors of no sentinel lymph node metastasis on a larger number of patients is required. The validation of these predictors in prospective studies may enable approximately half of early stage breast cancer patients with positive SLN to be staged with SLNB alone while avoiding the morbidity of unnecessary ALND.</abstract><cop>Cairo, Egypt</cop><pub>Cairo University, National Cancer Institute</pub><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1110-0362
ispartof Journal of Egyptian National Cancer Institute, 2012, Vol.24 (1), p.23-30
issn 1110-0362
1687-9996
language eng
recordid cdi_emarefa_primary_312849
source DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Breast
Cancer
Lymph nodes
الثدي
السرطان
title Predictors of non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph node : pilot study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T01%3A51%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-emarefa&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Predictors%20of%20non-sentinel%20lymph%20node%20metastasis%20in%20breast%20cancer%20patients%20with%20positive%20sentinel%20lymph%20node%20:%20pilot%20study&rft.jtitle=Journal%20of%20Egyptian%20National%20Cancer%20Institute&rft.au=al-Khalili,%20Khalid&rft.date=2012&rft.volume=24&rft.issue=1&rft.spage=23&rft.epage=30&rft.pages=23-30&rft.issn=1110-0362&rft.eissn=1687-9996&rft_id=info:doi/&rft_dat=%3Cemarefa%3E312849%3C/emarefa%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true